UnknownNot Applicable

Evaluation of Early Relapse After Mandibular Lengthening Surgery

Belgium50 participantsStarted 2018-09-11

Plain-language summary

The goal of this study is to evaluate whether the use of a bone graft substitute at the osteotomy site will result in better stability and diminish early relapse after mandibular lengthening surgery. The study focuses on the evaluation of the following hypothesis: The use of bone graft substitute at the osteotomy site has an influence on: * The 3-dimensional stability of the osteotomy site * Early relapse based in the plasticity of the site

Who can participate

Age range10 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Class II occlusion of non-syndromic origin, mandibular hypoplasia * Availability of pre- and postoperative CBCT scans of sufficient quality * Age: \>10years Exclusion Criteria: * Previous orthognathic surgical treatment * Simultaneously performed genioplasty * Plate osteosynthesis * Buccal plate fracture during surgery

What they're measuring

early relapse by means of three dimensional color maps (CBCT)

Timeframe: the first 6 months postoperatively

Trial details

NCT IDNCT03710512

SponsorUniversitair Ziekenhuis Brussel

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-09-01

Contact for this trial

Veerle Van Mossevelde, Datanurse

+32 2 476 31 34 veerle.vanmossevelde@uzbrussel.be

View on ClinicalTrials.gov More Mandibular Hypoplasia trials